Serum Response Factor Protects Retinal Ganglion Cells Against High-Glucose Damage

Journal of Molecular Neuroscience : MN
Yan CaoQiang Ma

Abstract

Serum response factor (SRF), which encodes the MADS-box family of related proteins, is a common transcription factor related to the expression of genes associated with cell survival. However, SRF's role in retinal ganglion cells (RGCs) after high-glucose injury remains unclear. In this study, we investigate the protective role of SRF after high-glucose injury and its underlying mechanism. The in vitro RGC model subjected to high glucose was established by employing a 50 mmol/L glucose culture environment. As detected by real-time quantitative PCR and Western blot, SRF was significantly upregulated in RGCs treated with high glucose. Overexpression of SRF significantly promoted survival among RGCs exposed to high glucose and inhibited RGC apoptosis. Knockdown of SRF exerted an inverse effect. Moreover, SRF upregulation enhanced expression of an antioxidant protein, nuclear factor erythroid 2-related factor (Nrf2), via control of the Fos-related antigen 1 (Fra-1). SRF upregulation also affected RGC survival after high-glucose treatment. Our findings showed that overexpression of SRF promoted survival of RGCs after high-glucose injury by regulating Fra-1 and Nrf2.

References

Sep 1, 1990·Journal of Virological Methods·A J Garrett, A Dunham
Oct 18, 2000·Free Radical Biology & Medicine·J ChandraS Orrenius
Feb 7, 2001·Molecular Endocrinology·K De BosscherG Haegeman
May 14, 2003·Progress in Retinal and Eye Research·Stefan IsenmannAlessandro Cellerino
Apr 14, 2004·Archives of Ophthalmology·John H KempenUNKNOWN Eye Diseases Prevalence Research Group
Apr 20, 2004·The Journal of Biological Chemistry·Marcello MaggioliniSebastiano Andò
Feb 12, 2005·Antioxidants & Redox Signaling·Makoto Kobayashi, Masayuki Yamamoto
Nov 1, 2006·Vascular Pharmacology·Allan D Callow
Sep 27, 2007·Ophthalmic Epidemiology·Barbara Eden Kobrin Klein
May 4, 2011·Diabetes, Obesity & Metabolism·M PortaF Mazzaglia
May 19, 2011·Biochemistry. Biokhimii︠a︡·V O TkachevN K Zenkov
Sep 24, 2011·Arteriosclerosis, Thrombosis, and Vascular Biology·Henrick N HoritaRaphael A Nemenoff
Feb 4, 2012·Diabetes Care·Joanne W Y YauUNKNOWN Meta-Analysis for Eye Disease (META-EYE) Study Group
Mar 7, 2012·Molecular and Cellular Biology·Michelle VazSekhar P Reddy
Nov 24, 2012·Arteriosclerosis, Thrombosis, and Vascular Biology·Xiaochun LongJoseph M Miano
Feb 5, 2013·Cell·Xuan ZhaoRonald M Evans
Mar 15, 2013·Proceedings of the National Academy of Sciences of the United States of America·Young-Jae NamEric N Olson
Mar 29, 2013·The Journal of Pharmacology and Experimental Therapeutics·Kyoung In JungChan Kee Park
Apr 6, 2013·Science·Christian BaarlinkRobert Grosse
Jul 16, 2014·Mechanisms of Development·Benedikt SchwartzPhillip Grote
Sep 10, 2014·Nucleic Acids Research·Gabriel Moquet-TorcyIsabelle Jariel-Encontre
Oct 8, 2014·The Journal of Experimental Medicine·Bettina GrötschJean-Pierre David
Mar 17, 2015·The Journal of Clinical Investigation·Bercin K CenikNing Liu

❮ Previous
Next ❯

Citations

Mar 13, 2019·International Journal of Environmental Research and Public Health·Declan Timothy Waugh
Jun 12, 2020·International Journal of Urology : Official Journal of the Japanese Urological Association·Long ZhaoYan Xu
May 13, 2020·International Journal of Molecular Sciences·Cristina AngeloniTullia Maraldi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis